help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2008-0646
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/7/2806    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Perticone, F.
Right arrow Articles by Sesti, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perticone, F.
Right arrow Articles by Sesti, G.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Cardiovascular Endocrinology
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 7 2806-2810
Copyright © 2008 by The Endocrine Society

Low-Plasma Insulin-Like Growth Factor-I Levels Are Associated with Impaired Endothelium-Dependent Vasodilatation in a Cohort of Untreated, Hypertensive Caucasian Subjects

Francesco Perticone, Angela Sciacqua, Maria Perticone, Irma Laino, Sofia Miceli, Ilaria Care', Giulia Galiano Leone, Francesco Andreozzi, Raffaele Maio and Giorgio Sesti

Department of Experimental and Clinical Medicine, University Magna Graecia, 88100 Catanzaro, Italy

Address all correspondence and requests for reprints to: Francesco Perticone, M.D., Department of Experimental and Clinical Medicine, Policlinico Mater Domini-Viale Europa, Campus Germaneto, 88100 Catanzaro, Italy. E-mail: perticone{at}unicz.it.

Context: Accumulating evidence suggests that IGF-I has protective vascular effects, supporting the possibility that IGF-I deficiency may contribute to atherosclerosis. However, the relationship between plasma IGF-I levels and endothelium-dependent vasodilatation is still unsettled.

Objective: We designed this present study to test the hypothesis that low-plasma IGF-I levels are associated with reduced endothelial function independently classical cardiovascular risk factors.

Setting: Outpatients were included in the study.

Patients: A total of 100 never-treated hypertensive Caucasian subjects participating in the CAtanzaro MEtabolic RIsk factors Study was recruited.

Interventions: Subjects underwent forearm blood flow (FBF) evaluation by strain-gauge plethysmography in response to increasing doses of acetylcholine (ACh) (Sigma, Milan, Italy) and sodium nitroprusside (Malesci, Florence, Italy). Insulin sensitivity was estimated by the homeostasis model assessment index.

Results: Plasma IGF-I levels were significantly correlated with age (r = –0.300; P = 0.001), high-density lipoprotein serum cholesterol (r = 0.211; P = 0.017), homeostasis model assessment index (r = –0.355; P <0.0001), systolic blood pressure (r = –0.174; P = 0.042), glomerular filtration rate (r = 0.228; P = 0.011), and ACh-stimulated FBF (r = 0.565; P <0.0001). In a stepwise forward multivariate regression analysis, the strongest predictors of ACh-stimulated FBF response were plasma IGF-I levels, accounting for 31.9% of its variation.

Conclusions: These results demonstrate, for the first time, that low-plasma IGF-I levels are highly associated with reduced endothelial function, an early step in atherogenesis process.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society